Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse

Psychopharmacology

Volumn 207, Issue 3, 2009, Pages 413-422

  Madia, Priyanka A ^a   Dighe, Shveta V ^a   Sirohi, Sunil ^a   Walker, Ellen A ^b   Yoburn, Byron C ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Acute treatment; Clocinnamox; Continuous infusion; Efficacy; Etorphine; Hydrocodone; Intermittent treatment; Methadone; Opioid analgesia; Oxycodone; Tolerance

Indexed keywords

CLOCINNAMOX; ETORPHINE; HYDROCODONE; METHADONE; MORPHINE; OXYCODONE; PLACEBO;

ACUTE DRUG ADMINISTRATION; ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; MINIPUMP; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; ETORPHINE; HYDROCODONE; INFUSIONS, INTRAVENOUS; MALE; METHADONE; MICE; OXYCODONE;

EID: 71349084746     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1673-6     Document Type: Article

References (24)

1. JW Black P Leff 1983 Operational models of pharmacological agonism Proc R Soc Lond B Biol Sci 220 141 162 10.1098/rspb.1983.0093 1:CAS:528: DyaL2cXmtFaqtA%3D%3D 6141562
2. CR Chapman HF Hill 1989 Prolonged morphine self-administration and addiction liability. Evaluation of two theories in a bone marrow transplant unit Cancer 63 1636 1644 10.1002/1097-0142(19890415)63:8<1636::AID- CNCR2820630834>3.0.CO;2-9 1:STN:280:DyaL1M7mvVSqtg%3D%3D 2466551 (Pubitemid 19093297)
3. R Chou JC Ballantyne GJ Fanciullo PG Fine C Miaskowski 2009 Research gaps on use of opioids for chronic noncancer pain: findings from the review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline J Pain 10 147 159 10.1016/j.jpain.2008.10.007 1:CAS:528:DC%2BD1MXhtlCgsbY%3D 19187891
4. MW Crawford C Hickey C Zaarour A Howard B Naser 2006 Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery Anesth Analg 102 1662 1667 10.1213/01.ane.0000216036.95705.c2 1:CAS:528:DC%2BD28XlsFOmsb8%3D 16717305 (Pubitemid 43799834)
5. SV Dighe PA Madia S Sirohi BC Yoburn 2009 Continuous morphine produces more tolerance than intermittent or acute treatment Pharmacol Biochem Behav 92 537 542 10.1016/j.pbb.2009.02.004 1:CAS:528:DC%2BD1MXjsFWrtrk%3D 19248799
6. A Duttaroy BC Yoburn 1995 The effect of intrinsic efficacy on opioid tolerance Anesthesiology 82 1226 1236 10.1097/00000542-199505000-00018 1:CAS:528:DyaK2MXmtlGht7k%3D 7741298
7. A Duttaroy R Kirtman F Farrell M Phillips J Philippe T Monderson BC Yoburn 1997 The effect of cumulative dosing on the analgesic potency of morphine in mice Pharmacol Biochem Behav 58 67 71 10.1016/S0091-3057(96)00463-7 1:CAS:528:DyaK2sXltFCqtbs%3D 9264072 (Pubitemid 27334354)
8. Finney DJ (1973) Probit analysis: a statistical treatment of the sigmoid response curve. Cambridge University Press, London
9. BL Kieffer 1999 Opioids: first lessons from knockout mice Trends Pharmacol Sci 20 19 26 10.1016/S0165-6147(98)01279-6 1:CAS:528: DyaK1MXks1amsbw%3D 10101958 (Pubitemid 29304521)
10. P Kumar S Sunkaraneni S Sirohi SV Dighe EA Walker BC Yoburn 2008 Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation Eur J Pharmacol 597 39 45 10.1016/j.ejphar.2008.08.025 1:CAS:528:DC%2BD1cXht1KmtbrI 18789923
11. BH McCarberg 2007 The treatment of breakthrough pain Pain Med 8 S8 S13 10.1111/j.1526-4637.2006.00270.x 17280601 (Pubitemid 46128736)
12. B Nicholson 2009 Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain Pain Pract 9 71 81 10.1111/j.1533-2500.2008.00232.x 19019047
13. CA Paronis SG Holtzman 1992 Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats J Pharmacol Exp Ther 262 1 9 1:CAS:528:DyaK38XkvVegur0%3D 1625189
14. M Pawar P Kumar S Sunkaraneni S Sirohi EA Walker BC Yoburn 2007 Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of μ-opioid receptors and dynamin-2 Eur J Pharmacol 563 92 101 10.1016/j.ejphar.2007.01.059 1:CAS:528:DC%2BD2sXksV2ktbw%3D 17349996 (Pubitemid 46602222)
15. A Rosenblum LA Marsch H Joseph RK Portenoy 2008 Opioids and the treatment of chronic pain: controversies, current status, and future directions Exp Clin Psychopharmacol 16 405 416 10.1037/a0013628 18837637
16. S Sirohi SV Dighe EA Walker BC Yoburn 2008 The analgesic efficacy of fentanyl: relationship to tolerance and μ-opioid receptor regulation Pharmacol Biochem Behav 91 115 120 10.1016/j.pbb.2008.06.019 1:CAS:528:DC%2BD1cXhtVylu77O 18640146
17. K Stafford AB Gomes J Shen BC Yoburn 2001 Mu-opioid receptor downregulation contributes to opioid tolerance in vivo Pharmacol Biochem Behav 69 233 237 10.1016/S0091-3057(01)00525-1 1:CAS:528:DC%2BD3MXksVGrtbo%3D 11420091 (Pubitemid 32566268)
18. CW Stevens TL Yaksh 1989 Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion J Pharmacol Exp Ther 250 1 8 1:CAS:528:DyaL1MXltVyrurY%3D 2526212
19. EA Walker AM Young 2001 Differential tolerance to antinociceptive effects of μ opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats Psychopharmacology (Berl) 154 131 142 10.1007/ s002130000620 1:CAS:528:DC%2BD3MXitlSlsr8%3D (Pubitemid 32186498)
20. Wolfram S (1991) A system for doing mathematics by computer. Mathematica. Addison-Wesley, Reading
21. BC Yoburn J Chen T Huang CE Inturrisi 1985 Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat J Pharmacol Exp Ther 235 282 286 1:CAS:528:DyaL28XhsVCltA%3D%3D 4057070
22. BC Yoburn A Cohen JG Umans GS Ling CE Inturrisi 1985 The graded and quantal nature of opioid analgesia in the rat tailflick assay Brain Res 331 327 336 10.1016/0006-8993(85)91558-6 1:CAS:528:DyaL2MXhvFOqs7k%3D 3986573 (Pubitemid 15115342)
23. G Zernig T Issaevitch JH Broadbear TF Burke JW Lewis GA Brine JH Woods 1995 Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding Life Sci 57 2113 2125 10.1016/0024-3205(95)02204-V 1:CAS:528:DyaK2MXptVyqsbk%3D 7475964
24. G Zernig T Issaevitch JH Woods 1996 Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches J Pharmacol Toxicol Methods 35 223 237 10.1016/1056-8719(96)00053-6 1:CAS:528:DyaK28XksFGjsbY%3D 8823669 (Pubitemid 26249102)